{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113762.1.4.1235.476",
  "meta" : {
    "versionId" : "6",
    "lastUpdated" : "2024-08-13T01:10:00.000-04:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail" : {
        "name" : "B.well Connected Health Author"
      }
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2024-08-13"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2024-08-13"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.476",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113762.1.4.1235.476"
    }
  ],
  "version" : "20240813",
  "name" : "OGTT_Grouping",
  "title" : "OGTT_Grouping",
  "status" : "active",
  "date" : "2024-08-13T01:10:00-04:00",
  "publisher" : "B.well Connected Health Steward",
  "description" : "b.well created value set by Sr. Clinical Business Analyst for OGTT - Oral glucose tolerance tests.",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: This value set's intent is to define the clinical codes that constitute the OGTT utilization in patients/users connected health.),(Data Element Scope: This value set's intent is to define the clinical codes that constitute the OGTT utilization in patients/users connected health.),(Inclusion Criteria: This value set's intent is to define the clinical codes that constitute the OGTT utilization in patients/users connected health.),(Exclusion Criteria: This value set's intent is to define the clinical codes that constitute the OGTT utilization in patients/users connected health.)",
  "compose" : {
    "include" : [
      {
        "valueSet" : [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.471"
        ]
      },
      {
        "valueSet" : [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.472"
        ]
      },
      {
        "valueSet" : [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.473"
        ]
      },
      {
        "valueSet" : [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.474"
        ]
      },
      {
        "valueSet" : [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.475"
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:eac87492-c3bc-40e7-8be4-4a692d2f55f7",
    "timestamp" : "2025-05-23T20:28:12-04:00",
    "total" : 16,
    "contains" : [
      {
        "system" : "http://loinc.org",
        "version" : "2.80",
        "code" : "1496-9",
        "display" : "Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 75 g glucose PO"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.80",
        "code" : "1507-3",
        "display" : "Glucose [Mass/volume] in Serum or Plasma --1 hour post 75 g glucose PO"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.80",
        "code" : "1518-0",
        "display" : "Glucose [Mass/volume] in Serum or Plasma --2 hours post 75 g glucose PO"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.80",
        "code" : "1533-9",
        "display" : "Glucose [Mass/volume] in Serum or Plasma --3 hours post 75 g glucose PO"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.80",
        "code" : "1539-6",
        "display" : "Glucose [Mass/volume] in Serum or Plasma --4 hours post 75 g glucose PO"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.80",
        "code" : "21004-7",
        "display" : "Glucose tolerance [Interpretation] in Serum or Plasma"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.80",
        "code" : "49688-5",
        "display" : "Glucose tolerance [Interpretation] in Serum or Plasma Narrative--post 75 g glucose PO"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.80",
        "code" : "50667-5",
        "display" : "Glucose tolerance [Interpretation] in Serum or Plasma Narrative"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.80",
        "code" : "62856-0",
        "display" : "PhenX - oral glucose tolerance test protocol 141001"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.80",
        "code" : "6749-6",
        "display" : "Glucose [Mass/volume] in Serum or Plasma --2.5 hours post 75 g glucose PO"
      },
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "version" : "2025",
        "code" : "82951",
        "display" : "Glucose; tolerance test (GTT), 3 specimens (includes glucose)"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.80",
        "code" : "LA33717-2",
        "display" : "Impaired glucose tolerance"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.80",
        "code" : "LP112419-9",
        "display" : "PhenX - oral glucose tolerance test protocol 141001"
      },
      {
        "system" : "http://loinc.org",
        "version" : "2.80",
        "code" : "LP65536-2",
        "display" : "Glucose tolerance 3H panel"
      },
      {
        "system" : "http://hl7.org/fhir/sid/icd-10-cm",
        "version" : "2025",
        "code" : "R73.0",
        "display" : "Abnormal glucose"
      },
      {
        "system" : "http://hl7.org/fhir/sid/icd-10-cm",
        "version" : "2025",
        "code" : "R73.02",
        "display" : "Impaired glucose tolerance (oral)"
      }
    ]
  }
}
